Close Menu

NEW YORK (GenomeWeb) – Curetis said today that its subsidiary Ares Genetics has entered into a licensing agreement with Qiagen for Ares' bioinformatics tools for antimicrobial resistance (AMR) research.

Under the agreement Qiagen has received an exclusive license to develop and commercialize general bioinformatics offerings and services for AMR research based on ARESdb, a database containing genetic information on AMR, and AREStools, a bioinformatics toolbox.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.